Prognostic impact of breast cancer (BC) subtype in elderly patients.
Elisabeth Bergen(Medical University of Vienna), Rupert Bartsch(Universitätszahnklinik Wien), Anna S. Berghoff(Medical University of Vienna), Cornelia Tichy(Comprehensive Cancer Center Vienna), Guenther G. Steger(Mount Vernon Hospital), Karin Dieckmann(University of Vienna), Matthias Preusser(Medical University of Vienna), Margaretha Rudas(Comprehensive Cancer Center Vienna), Peter Dubsky(Hirslanden Klinik St. Anna), Christoph Zielinski(Vienna General Hospital), Zsuzsanna Bagó-Horváth(Comprehensive Cancer Center Vienna), Robert M. Mader(Centre de Recherche en Économie et Management), Michael Gnant(Austrian Breast & Colorectal Cancer Study Group)
Cited by 0
Related Papers
Breast cancer
|Nature Reviews Disease Primers|2019|2.9k
Breast cancer
|The Lancet|2016|2.3k
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
|Journal of Clinical Oncology|2010|1.6k